Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

University Medicine Greifswald500 enrolled

Overview

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock. Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Sepsis Septic Shock

Interventions

bedside blood cultureOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a new diagnosed sepsis or septic shock: emergency department, operating theatre, intensive care unit and planed blood culture diagnostics. * informed written consent Exclusion Criteria: * Pediatric patients (\< 18 Years) * DNR-order

Locations (1)

Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany

Greifswald, Germany

RECRUITING

Outcomes

Primary Outcomes

Time to a significant change of antimicrobial therapy from the time of the diagnosis of sepsis or septic shock

Time frame: Nov. 2016 - Nov. 2017

Central Contacts

Matthias Gründling, MD

CONTACT

gruendli@uni-greifswald.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.